David Leppert
University of Basel · 368 works · 17,927 citations · h-index 66
Top works
- Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
- T cell gelatinases mediate basement membrane transmigration in vitro.
- Matrix metalloproteinases in immunity
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients.
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- Ofatumumab versus Teriflunomide in Multiple Sclerosis
- Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
- Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
- PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane
- Serum neurofilament light levels in normal aging and their association with morphologic brain changes
- Antiadhesive properties of biological surfaces are protective against stimulated granulocytes.
- Rare Deletions at 16p13.11 Predispose to a Diverse Spectrum of Sporadic Epilepsy Syndromes
- Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
- Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients